Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe
ESMO Open(2023)
摘要
The EMA recommendations have supported the implementation of DPD deficiency testing in Europe. Key factors for successful implementation were test reimbursement and clear clinical guidelines. Further efforts to improve the oncologists' awareness of the clinical relevance of DPD testing in clinical practice are needed.
更多查看译文
关键词
DPD deficiency,DPYD,fluoropyrimidine,implementation survey,pre-therapeutic testing,toxicity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要